ACE2 and diabetes mellitus: Because ACE2 is upregulated in patients with diabetes and cardiovascular disease who are treated with ACEI and ARBs, this creates a controversy regarding these treatments (Albini et al., 2020; AlGhatrif et al., 2020; Fang et al., 2020; Onweni et al., 2020).